Renaissance Technologies »

Mural Oncology shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $729k 232k 3.14
2024-03-31 $1.1M 217k 4.89

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Vertex Pharmaceuticals Incorporated (VRTX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Broadcom (AVGO)
Tesla Motors (TSLA)
Sprouts Fmrs Mkt (SFM)
Franco-Nevada Corporation (FNV)
Apple (AAPL)
Gilead Sciences (GILD)
Exelixis (EXEL)

View all positions for Renaissance Technologies

Top funds holding Mural Oncology

Armistice Capital
Solas Capital Management
Vanguard Group
Westfield Capital Management Company
Alta Fundamental Advisers
Newtyn Management
Verition Fund Management
Prosight Management
BlackRock
Acadian Asset Management
Alpine Partners VI
PRIMECAP Management Company
Renaissance Technologies
Centiva Capital
Geode Capital Management

View all funds holding Mural Oncology